+ All Categories
Home > Documents > Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and...

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and...

Date post: 23-Dec-2015
Category:
Upload: jane-black
View: 219 times
Download: 3 times
Share this document with a friend
Popular Tags:
32
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists
Transcript
Page 1: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Chapter 14

Muscarinic Agonists and Antagonists

Page 2: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

2Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Cholinergic Drugs

Agents that influence the activity of cholinergic receptors

Most mimic or block the actions of acetylcholine.

Cholinesterase inhibitors Indirectly prevent the breakdown of acetylcholine

Page 3: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

3Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Cholinergic Drugs

Toxicology encompasses Nicotine Insecticides Chemical warfare

Page 4: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

4Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Page 5: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

5Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Tips for Understanding the Cholinergic Drugs

Know the receptors that the drug affects. Know the normal responses to activation of

those receptors. Know whether the drug in question increases

or decreases receptor activation.

Page 6: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

6Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Master Keys to Cholinergic Drugs

Page 7: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

7Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Master Keys to Cholinergic Drugs

Page 8: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

8Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists and Antagonists

Muscarinic agonists Bethanechol Other muscarinic agonists Toxicology of muscarinic agonists

Muscarinic antagonists (anticholinergic drugs) Atropine Anticholinergic drugs for overactive bladder (urge

incontinence) Other muscarinic antagonists Toxicology of muscarinic antagonists

Page 9: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

9Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Tips for Understanding the Cholinergic Drugs

Bethanechol (prototype drug) Selective agonist at muscarinic cholinergic receptors Refer to Table 14-2. Note the effects muscarinic receptors can produce. Bethanechol activates muscarinic receptors (agonist). Know which receptors a drug interacts with

(Table 14-2) and what those receptors do (Table 14-2). You can predict the types of responses you might expect

from bethanechol.

Page 10: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

10Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists and Antagonists

Muscarinic agonists Bethanechol Other muscarinic agonists Toxicology of muscarinic agonists

Page 11: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

11Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists and Antagonists

Principal structures affected by muscarinic activation Heart: bradycardia Exocrine glands: increase sweating, salivation,

bronchial secretions, and secretion of gastric acid Smooth muscles

• Contraction in lung (constriction) • GI tract (increased tone/motility) • Bladder (contraction of detrusor) • Vascular (relaxation, vasodilation, hypotension)• Eye (pupillary constriction and ciliary contraction)

Page 12: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

12Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists

Bethanechol Mechanism of action

Pharmacologic effects Pharmacokinetics

Therapeutic uses Urinary retention Gastrointestinal uses

Page 13: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

13Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Agonists

Adverse effects Cardiovascular system Alimentary system Urinary tract Exacerbation of asthma Dysrhythmias in hyperthyroid patients

Preparations, dosage, and administration

Page 14: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

14Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Fig. 14-1. Structures of muscarinic agonists.

Page 15: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

15Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Other Muscarinic Agonists

Cevimeline Actions and uses Adverse effects Drug interactions Preparations, dosage, and administration

Page 16: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

16Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Other Muscarinic Agonists

Pilocarpine Glaucoma

Acetylcholine Miosis

Muscarine Present in poisonous mushrooms

Page 17: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

17Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Overactive Bladder

Also known as urgency incontinence, detrusor instability, and sometimes “can’t-hold-it-anymore” incontinence

Four major symptoms: urinary urgency, urinary frequency, nocturia, and urge incontinence

Urge incontinence often results from involuntary contractions of the bladder detrusor.

Page 18: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

18Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Overactive Bladder

Affects up to one-third of Americans Can develop at any age, but is most

predominant in elderly patients Two modes of treatment: behavioral therapy

and drug therapy If ineffective—percutaneous tibial nerve

stimulation (PTNS) may be tried.

Page 19: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

19Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Competitively block the actions of acetylcholine at muscarinic receptors

Most muscarinic receptors on structures innervated by parasympathetic nerves

Also known as parasympatholytic drugs, antimuscarinic drugs, muscarinic blockers, and anticholinergic drugs

Anticholinergic drugs: produce selective blockade of muscarinic receptors—not all cholinergic receptors

Page 20: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

20Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Certain drugs (antihistamines, tricyclic antidepressants, phenothiazine antipsychotics) have prominent antimuscarinic actions.

Use with caution—or not at all—with patients receiving other muscarinic antagonists.

Page 21: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

21Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine Best known muscarinic antagonist Found in nature Mechanism of action

• No direct effect of its own• Muscarinic receptor blockade

Page 22: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

22Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine Pharmacologic effects (receptor blockade)

• Heart• Exocrine glands• Smooth muscle• Eye• CNS• Dose dependency of muscarinic blockade• Pharmacokinetics

Page 23: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

23Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine (cont’d) Therapeutic uses

• Preanesthetic medication• Disorders of the eye• Bradycardia• Intestinal hypertonicity and hypermotility• Muscarinic agonist poisoning• Peptic ulcer disease• Asthma• Biliary colic

Page 24: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

24Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine (cont’d) Adverse effects

• Xerostomia (dry mouth)• Blurred vision and photophobia• Elevation of intraocular pressure• Urinary retention• Constipation• Anhidrosis• Tachycardia• Asthma

Page 25: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

25Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Muscarinic Antagonists(Anticholinergic Drugs)

Atropine (cont’d) Drug interactions

• Avoid combining atropine with other drugs capable of causing muscarinic blockade

Preparations, dosage, and administration• General systemic therapy• AtroPen for cholinesterase inhibitor poisoning• Ophthalmology

Page 26: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

26Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Anticholinergic Drugs for Overactive Bladder

Overactive bladder (OAB): characteristics and overview of treatment

Introduction to anticholinergic therapy of OAB Specific anticholinergic drugs for OAB

Oxybutynin (Ditropan, Oxytrol, Gelnique)• Syrup• Extended-release tablets• Transdermal patch and gel

Page 27: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

27Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Anticholinergic Drugs for Overactive Bladder

Specific anticholinergic drugs for OAB (cont’d) Darifenacin Solifenacin Tolterodine

• Immediate-release tablets• Extended-release capsules

Trospium Fesoterodine

Page 28: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

28Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Other Muscarinic Antagonists

Scopolamine Ipratropium bromide Antisecretory anticholinergics Dicyclomine Pirenzepine and telenzepine Mydriatic-cycloplegics Centrally acting anticholinergics

Page 29: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

29Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Agonists

Source of muscarinic poisoning Direct-acting muscarinic agonists Cholinesterase inhibitors

Symptoms Result from excessive activation of muscarinic

receptors Treatment

Muscarinic blocking agent, such as atropine

Page 30: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

30Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Antagonists

Sources of antimuscarinic poisoning Natural products Selective antimuscarinic drugs Drugs with pronounced antimuscarinic properties

Page 31: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

31Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Antagonists

Symptoms Dry mouth Blurred vision Photophobia Hyperthermia CNS effects Hot, dry, and flushed skin

Page 32: Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.

32Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Toxicology of Muscarinic Antagonists

Treatment Physostigmine Inhibitor of acetylcholinesterase

Warning Differentiate between poisoning and an actual

psychotic episode!


Recommended